Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study

This qualitative interview study (n=17) of those receiving esketamine (35-210mg/70kg, 12x over 6w) for depression explores patients’ experiences. Findings reveal highly variable effects of ketamine with common psychological distress, and central themes include perceptual effects, detachment, stillness and openness, mystical-type effects, fear and anxiety, feeling hungover and tired, and a neutralizing mood effect post-session. While patients reported several esketamine effects with psychotherapeutic potential such as increased openness, detachment, and mystical-type experiences, the study identifies a need for additional support due to the frequency and severity of the perceived distress during the treatment.

Abstract of Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression

Background Ketamine and its enantiomers are widely researched and increasingly used to treat mental disorders, especially treatment-resistant depression. The phenomenology of ketamine-induced experiences and their relation to its psychotherapeutic potential have not yet been systematically investigated.

Aims To describe the phenomenology of patient experiences during oral esketamine treatment for treatment-resistant depression (TRD) and to explore the potential therapeutic relevance of these experiences.

Methods In-depth interviews were conducted with 17 patients after a 6-week, twice-weekly ‘off label’ generic oral esketamine (0.5–3.0mg/kg) treatment program. Interviews explored participants’ perspectives, expectations, and experiences with oral esketamine treatment. Audio interviews were transcribed and analyzed using an Interpretative Phenomenological Analysis (IPA) framework.

Results The effects of ketamine were highly variable, and psychological distress was common in most patients. Key themes included (a) perceptual effects (auditory, visual, proprioceptive), (b) detachment (from body, self, emotions, and the world), (c) stillness and openness, (d) mystical-type effects (transcendence, relativeness, spirituality), and (e) fear and anxiety. Key themes related to post-session reports included (a) feeling hungover and fatigued, and (b) lifting the blanket: neutralizing mood effects.

Conclusion Patients reported several esketamine effects with psychotherapeutic potential, such as increased openness, detachment, an interruption of negativity, and mystical-type experiences. These experiences deserve to be explored further to enhance treatment outcomes in patients with TRD. Given the frequency and severity of the perceived distress, we identify a need for additional support in all stages of esketamine treatment.”

Authors: Joost J. Breeksema, Alistair Niemeijer, Bouwe Kuin, Jolien Veraart, Eric Vermetten, Jeanine Kamphuis, Wim van den Brink & Robert Schoevers

Summary of Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression

Research into the antidepressant potential of ketamine has increased since the early 2000s. Its psychoactive effects include altered perceptual processes, altered proprioception, alterations in consciousness, detachment from the world or self, and occasionally ‘mystical’ experiences.

Ketamine and its enantiomers are a regular pharmacological treatment without explicit psychological support or psychotherapy. Some therapists integrate ketamine administrations in a broader psychotherapeutic framework as ketamine-assisted psychotherapy, but no evidence-based treatments exist.

To access this content, you must purchase one of the following memberships: Pro Membership, Pro Membership Unlimited, Business Membership or Business Membership Unlimited. The membership will give you access to exclusive data, including summaries of psychedelic research papers, extended company info, and our member-only visualisations. Save yourself multiple hours each week by accessing Blossom’s resource library.

Find this paper

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study

https://doi.org/10.1007/s00213-023-06388-6

Open Access | Google Scholar | Backup | 🕊

Cite this paper (APA)

Breeksema, J. J., Niemeijer, A., Kuin, B., Veraart, J., Vermetten, E., Kamphuis, J., ... & Schoevers, R. (2023). Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study. Psychopharmacology, 1-14.

Study details

Compounds studied
Ketamine

Topics studied
Treatment-Resistant Depression Depression

Study characteristics
Interviews Qualitative

Participants
17 Humans

Authors

Authors associated with this publication with profiles on Blossom

Joost Breeksema
Joost J. Breeksema is a researcher (PhD candidate) and director of ICPR and the OPEN Foundation. He is one of the central connectors in the (European) psychedelic space.

Compound Details

The psychedelics given at which dose and how many times

Ketamine 35 - 210
mg | 12x

Linked Research Papers

Notable research papers that build on or are influenced by this paper

Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences
This longitudinal interview study (n=12) examined the subjective expectations and effects of ketamine treatment (35mg/70kg) in a population with treatment-resistant depression (TRD). The study found high expectations, side-effects for most (11/12), a reduction in suicidal ideation (SI) for many (8/12) but for some (3/12) more SI when treatment effects decreased (1 week later).

PDF of Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study